Study design and participation.

KF Kamille Fogh
AE Alexandra R. R. Eriksen
TL Tine Graakjær Larsen
RH Rasmus B. Hasselbalch
HB Henning Bundgaard
BS Bibi F. S. S. Scharff
SN Susanne D. Nielsen
CJ Charlotte S. Jørgensen
CE Christian Erikstrup
Lars Østergaard
SE Svend Ellermann-Eriksen
BA Berit Andersen
HN Henrik Nielsen
IJ Isik S. Johansen
LW Lothar Wiese
LH Lotte Hindhede
SM Susan Mikkelsen
SS Susanne G. Sækmose
BA Bitten Aagaard
DH Dorte K. Holm
LH Lene Harritshøj
LS Lone Simonsen
TF Thea K. Fischer
FF Fredrik Folke
FL Freddy Lippert
SO Sisse R. Ostrowski
TB Thomas Benfield
KM Kåre Mølbak
SE Steen Ethelberg
AK Anders Koch
AV Anne-Marie Vangsted
TK Tyra Grove Krause
AF Anders Fomsgaard
HU Henrik Ullum
RS Robert Skov
KI Kasper Iversen
ask Ask a question
Favorite

In collaboration with the Danish Union of Pedagogues (BUPL), a nationwide cross-sectional surveillance study among 47,810 union members and employees over the age of 15 years at DCS was carried out in February and March 2021 as part of the nationwide large-scale study Testing Denmark (17, 22, 26). Participants from selected DCS were invited to perform an individual POCT at work, identifying previous infection by detecting IgM and/or IgG antibodies and responding to an electronic questionnaire in the Research Electronic Data Capture database (REDCap). Employees affiliated with BUPL represent both municipal, self-governing, small, or large DCS and work with children aged 0 to 10 years old. In Denmark, 60,136 individuals are working in DCS (27), and approximately 60.000 are members of the BUPL (28).

Invitation letters and test material (POCT, a small container of detection buffer, capillary tubes, and finger prickers) were sent to DCS members in Denmark.

The POCT (CTK Biotech inc., Poway, CA, USA) was performed as a self-test and read by participants individually. POCT sensitivity and specificity were reported to be 96.9% (95% CI, 96.7 to 98.5%) and 99.4% (95% CI, 97.8 to 99.8%) by the manufacturer, respectively (29). A comparative study (cases, 30 people; controls, 10) revealed a slightly lower sensitivity of 90.0% and a 100% specificity (30). A study of 129 nonhospitalized versus 31 hospitalized SARS-CoV-2 patients revealed that the Wantai assay had a sensitivity of 96.7 (95% CI, 92.4 to 98.6) and a specificity of 99.5 (95% CI, 98.7 to 99.8) (31).

A call center was established for participants to contact if they had any questions. The project homepage (www.vitesterdanmark.dk) included information about the project as well as detailed information about the test procedure in Danish.

The questionnaire included questions about risk factors, symptoms, household members, employment, and behavior according to recommendations from the Danish Health Authority (see Fig. S1 in the supplemental material).

As a proxy for the general Danish population, we obtained access to data on seroprevalence in the same period from a convenience sample of unvaccinated Danish blood donors (SARS-CoV-2 total Ig ELISA; Wantai Biological Pharmacy Enterprise, Co, Ltd.), with a median age of 42 years, and 51.3% were male (31, 32).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A